Publications by authors named "J Chinitz"
COVID-19 vaccination and atrial fibrillation: When pandemics collide.
J Cardiovasc Electrophysiol
September 2024
Background: Advances in leadless pacemaker technology have enabled accelerometer-based atrioventricular (AV) synchronous pacing by sensing atrial mechanical contraction.
Objective: The purpose of this study was to report the performance of the Micra AV leadless pacemaker from the worldwide Micra AV post-approval registry (PAR) through 12 months.
Methods: The Micra AV PAR is a prospective, single-arm, observational registry designed to assess the safety and effectiveness of Micra AV in a real-world setting.
Article Synopsis
- The OmniaSecure defibrillation lead is a new, small-diameter lead aimed at improving targeted placement for better long-term performance in implantable cardioverter-defibrillators.
- The LEADR pivotal clinical trial involved 643 patients and showed that the lead was successfully placed in the correct position for 99.5% of participants, with a 97.5% success rate for defibrillation at implantation.
- The trial results indicated high safety and efficacy, with a 97.1% freedom from major complications and no lead fractures over an average follow-up of 12.7 months.
Background: Conduction disturbances are a common complication of transcatheter aortic valve replacement (TAVR). Mobile Cardiac Telemetry (MCT) allows for continuous monitoring with near "real time" alerts and has allowed for timely detection of conduction abnormalities and pacemaker placement in small trials. A standardized, systematic approach utilizing MCT devices post TAVR has not been widely implemented, leading to variation in use across hospital systems.
View Article and Find Full Text PDFMitigating esophageal injury after atrial fibrillation ablation guided by ablation index; CLOSEr to goal.
J Cardiovasc Electrophysiol
November 2022